DYN NASDAQ
Dyne Therapeutics, Inc.
1W: -5.0%
1M: -11.7%
3M: +16.7%
YTD: -6.1%
1Y: +40.8%
3Y: +30.1%
5Y: -0.6%
$17.37
+0.00 (+0.00%)
Weekly Expected Move ±7.8%
$15
$16
$17
$19
$20
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-452M
Net Income
-23.0% YoY
$-462M
Free Cash Flow
-43.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-56.4%
ROA-48.1%
ROIC315.0%
Valuation
P/E-6.4
P/B3.3
EV/EBITDA-4.3
Leverage
Debt/Equity0.02
Current Ratio22.25
Interest Cov.-42.6x
Quality Scores
Piotroski F4/9
Altman Z6.57
Beneish M0.00